4//SEC Filing
Zinda Michael 4
Accession 0001415889-25-007238
CIK 0001808158other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:00 PM ET
Size
9.8 KB
Accession
0001415889-25-007238
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Shares
2025-03-04+14,000→ 85,908 total - Award
Employee Stock Option (right to buy)
2025-03-04+75,000→ 75,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (75,000 underlying) - Award
Employee Stock Option (right to buy)
2025-03-04+85,000→ 85,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (85,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
- [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815366
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:00 PM ET
- Size
- 9.8 KB